
Conditions: Advanced Solid Tumors
Interventions: Drug: SHR-7631
Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Not yet recruiting



Conditions: Advanced Solid Tumors
Interventions: Drug: SHR-7631
Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Not yet recruiting
Background Patients with advanced prostate cancer that does not respond to hormone therapy often have a poor outlook. New treatment options are needed. The TALAPRO-2 study found that combining talazoparib…
“`html A Randomized Controlled Pilot Trial of Primary Care Treatment Integrating Motivation and Exposure Treatment (PC-TIME) in Veterans With PTSD and Harmful Alcohol Use The Impact of PC-TIME on PTSD…
Objective The goal of this study was to evaluate the safety of bemdaneprocel and its effects on health outcomes for people with Parkinson’s disease (PD) over a period of 24…
Study Overview This study focused on understanding how reliable certain measurements are when using a specific exercise called the countermovement jump. It also looked at how well these measurements can…
Understanding the Trial Results The study looked at a treatment called upadacitinib, which can be used alone or with another drug called elsubrutinib, for people with systemic lupus erythematosus (SLE),…
Background This study looked at how certain diabetes medications combined with a high-protein diet and moderate exercise can help people with obesity and newly diagnosed prediabetes or type 2 diabetes…
“`html Background Chronic heart failure is a serious condition with high rates of illness and death. About half of the patients diagnosed with it die within five years. New treatments…